B+
Bull case
20%
Probability
Target price
$1.60
Analysis reference price unavailable
Analysis 2026-11-06 · RankAlpha Sentiment Codex
XCUR
ExicureDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
$0.89-$0.06 (-6.26%)
At close · 2026-11-09
Current thesis
A timely, credible financing or strategic transaction could extend runway and support GPCR program development. This is an option-value case, not a confirmed transaction [#10-Q-2026-08-14].
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.1.
What can break
Cash runway, dilution, and potential inability to fund operations [#10-Q-2026-08-14].
Momentum
88
Value
41
Sentiment
37
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.75 · Bull $1.60 · Bear $0.15Analysis 2026-11-06; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-11-09 • Vendor: Data Vendor v1
Scores
As of 2026-11-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-11-06 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-11-09
Investment thesis
As of 2026-11-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-11-09. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Why
Momentum88 · Δ7d -
Value41 · Δ7d +0.1
Sentiment37 · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta +0.1.
Contradictions & invalidation
- • Cash runway, dilution, and potential inability to fund operations [#10-Q-2026-08-14].
- • Failure to regain Nasdaq stockholders’ equity compliance by December 2, 2026 could trigger a delisting determination [#8-K-2026-09-16].
- • The last verified quarter showed no revenue, $1.7 million of cash, and substantial going-concern doubt; financing and the December 2 listing deadline may dominate clinical optionality [#10-Q-2026-08-14] [#8-K-2026-09-16].
Catalyst clock
2026-11-30
Unverified scheduled earnings follow-up
Lead driver: Value · See fundamentals
Momentum
88
18% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
43% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.0
Sentiment
37
39% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 87.9 / Value 40.7 / Sentiment 36.9
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-11-06. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$0.75
Analysis reference price unavailable
Analysis 2026-11-06 · RankAlpha Sentiment Codex
B-
Bear case
35%
Probability
Target price
$0.15
Analysis reference price unavailable
Analysis 2026-11-06 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-11-09
Fundamentals (TTM)
As of 2026-11-09
Market Cap
$5.83M
Beta
4.11
Shares Out
6.55M
P/E (TTM) · Derived
-1.1
P/S (TTM)
-
P/FCF (TTM) · Derived
-0.88
Rev YoY
-100.0%
EPS YoY
-57.6%
Gross Margin
-64.8%
Op Margin
-2365.0%
Net Debt
-$3.57M
Current Ratio
0.56
As of 2026-11-09 • Updated nightlySource: Internal modelMethods & Data